Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage; Associations with degenerative changes

Arthritis and Rheumatism

Volumn 44, Issue 3, 2001, Pages 585-594

  Tetlow, Lynne C ^a,b   Adlam, Daman J ^a,b   Woolley, David E ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; CYTOKINE; FIXATIVE; GELATIN; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; PARAFFIN; PHORBOL 13 ACETATE 12 MYRISTATE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ARTHROPLASTY; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CELL INTERACTION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING; ZYMOGRAPHY;

AGED; CARTILAGE, ARTICULAR; CHONDROCYTES; COLLAGENASES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; OSTEOARTHRITIS, KNEE; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035076487     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C     Document Type: Article

References (41)

1. Etiopathogenesis of osteoarthritis
2. Cartilage in health and disease
3. Role of metalloproteinases in human osteoarthritis
4. Osteoarthritic lesions: Involvement of three different collagenases
5. Gene expression of matrix metalloproteinase 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific
6. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis
7. In situ zymographic localisation of type II collagen degrading activity in osteoarthritic human cartilage
8. Enhanced cleavage of type II collagen by collagenases in osteoarthritic cartilage
9. Cellular biology of cartilage degradation
10. Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes
11. Tumour necrosis factor-alpha (TNF-alpha) in canine osteoarthritis: Immunolocalization of TNF-alpha, stromelysin and TNF receptors in canine osteoarthritic cartilage
12. Discoordinate expression of stromelysin, collagenase and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts: Synergistic effects of interleukin-1 and tumour necrosis factor-alpha on stromelysin expression
13. Cytokine regulation of chondrocyte functions
14. The in vivo effects of intraarticular corticosteroid injection on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis
15. Role of interleukin-1, tumor necrosis factor α and interleukin-6 in cartilage proteoglycan metabolism and destruction: Effect of in situ blocking in murine antigen- and zymosan-induced arthritis
16. Excess of metalloproteinase over tissue inhibitor of metalloproteinases may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis
17. The reliability of the Mankin score for osteoarthritis
18. Mast cell proteinases activate precursor forms of collagenase (pMMP-1) and stromelysin (pMMP-3) but not gelatinases A and B (pMMP-2 and pMMP-9)
19. Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivo
20. Human synovium releases a factor which stimulates chondrocyte production of PGE and plasminogen activator
21. Prostromelysin and procollagenase genes are differentially up-regulated in chondrocytes from the knees of rabbits with experimental osteoarthritis
22. Proteinases and connective tissue breakdown
23. Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage
24. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1)
25. Immunohistochemical analysis of several proteolytic enzymes as parameters of cartilage degradation
26. Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitors
27. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase
28. Heterogeneity of articular chondrocytes and cartilage matrix
29. Cloning, expression and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage
30. Collagenase-3 (matrix metalloproteinase 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: In vitro mimicking effect by transforming growth factor α
31. Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: An immunohistochemical study
32. Regulation of metalloproteinase gene expression: Implications for osteoarthritis
33. Production of cytokines by chondrocytes and its role in proteoglycan degradation
34. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis
35. Mechanisms of tissue destruction in rheumatoid arthritis
36. Chondrocyte matrix metalloproteinase-8: Up-regulation of neutrophil collagenase by interleukin-1 β in human cartilage from knee and ankle joints
37. Microheterogeneity of acute phase proteins in patients with clinically active and clinically non-active osteoarthritis
38. Detection of cytokines at the cartilage pannus junction in patients with rheumatoid arthritis: Implications for the role of cytokines in cartilage destruction and repair
39. Mast cells, cytokines, and matrix metalloproteinases at the rheumatoid lesion: Dual immunolocalisation studies
40. TNFα - A pivotal role in rheumatoid arthritis?
41. Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage